[Current medical treatment of retinal venous thrombosis. Considerations on 100 cases with 1 to 5-year follow-up].
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000188:drug therapy; D012169:Retinal Vein; D013924:Thrombophlebitis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D000925:Anticoagulants; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Le traitement médical actuel des thromboses veineuses rétiniennes. Considérations sur 100 cas avec recul de 1 à 5 ans.